Skip to content

OraQuick HIV Self-Test

by OraSure Technologies, Inc. 17 variants

Ref 1001-0602U

OraQuick HIV Self-Test (1001-0602U) is an in vitro diagnostic device (EU IVDD Annex II List A; EMDN category HIV 1 / 2 - rt & poc) made by OraSure Technologies, Inc., registered in EUDAMED on 12 May 2026 (Basic UDI-DI B-00608337001525), active as of 25 Oct 2026.

Active European Union

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-00608337001525 Basic UDI-DI 00608337001525UDI-DIDate12 May 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDD Active

Specification

EUDAMED

Device name
OraQuick HIV Self-Test, Single Unit, CE, Germany
Model / reference
1001-0602U
Primary DI / UDI-DI
00608337001525
Basic UDI-DI
B-00608337001525
EMDN code
W0105090302 HIV 1 / 2 - rt & poc
Device class
Class IVD Annex II List A
EU registration type
Legacy device (under a directive)
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
US-MF-000009941
Authorised representative
QbD RepS BV BE-AR-000000040

Similar devices in this category

Other devices filed under HIV 1 / 2 - RT & POC.

Other devices from OraSure Technologies, Inc.

See all devices from OraSure Technologies, Inc. →

Properties

  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • IVD kit
  • Self-testing
Other properties (8, all answered No)